Live Chat
Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    editor, Srdan Verstovsek.
    Contents:
    Novel insights into myelofibrosis pathophysiology and treatment / Srdan Verstovsek
    Primary myelofibrosis : diagnosis and risk stratification / Ben Y. Zhang & Naseema Gangat
    Prognostication in myelofibrosis / Francesco Passamonti, Domenica Caramazza, Barbara Mora & Margherita Maffioli
    Prognostic relevance of mutations in myelofibrosis / Paola Guglielmelli, Giada Rotunno, Annalisa Pacilli & Carmela Mannarelli
    Disease burden for the patient with myelofibrosis : goals and response with therapy / Holly L. Geyer & Ruben A. Mesa
    Myeloproliferative neoplasms and splanchnic vein thrombosis / Giovanni Barosi & Vittorio Rosti
    Interferon therapy for myelofibrosis / Hans Carl Hasselbalch
    JAK inhibitors as therapy for myelofibrosis / Srdan Verstovsek & Kate J. Newberry
    What we can do about anemia in myelofibrosis / Francisco Cervantes & Arturo Pereira
    Rationale for combination therapies in myelofibrosis / Alessandro M. Vannucchi, Niccolò Bartalucci, Lisa Pieri & Paola Guglielmelli
    When and how to transplant patients with myelofibrosis / H. Joachim Deeg, Olga Sala-Torra & Bart L. Scot.
    Digital Access Future Med 2015
  • Article
    Waller T, Morein B, Fabiansson E.
    Lab Anim. 1978 Jul;12(3):145-8.
    Parenteral administration of Encephalitozoon cuniculi induced an antibody response within 7--11 days. Peroral administration was less effective since only 2 of 6 animals showed seroconversion; they became seropositive within 14--21 days. Sera from animals which became seropositive had high antibody titres during the whole test period. Immune sera from 3 animals were fractionated by gel filtration. With the india-ink immunoreaction test, antibodies to E. cuniculi were found only in the 7S fractions, while the indirect fluorescent-antibody test detected them in fractions 19S and 7S. The 7S fractions were identified as IgG and the 19S fractions as IgM. A program for eradication of encephalitozoonosis, based on these results, is discussed.
    Digital Access Access Options